| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/01/2006 | US7084155 Chemokine receptor binding heterocyclic compounds |
| 08/01/2006 | US7084142 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7083680 Sublimation and purification method |
| 07/27/2006 | WO2006078697A1 Bicyclic heterocycles as cannabinoid receptor modulators |
| 07/27/2006 | WO2006077851A1 Quinolone derivative and salt thereof |
| 07/27/2006 | US20060167260 Subjecting a solution of alkyl (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate to liquid chromatography treatment using uncoated silica gel as the packing material for separating epimers |
| 07/27/2006 | US20060167244 Polymerisation inhibitor |
| 07/27/2006 | US20060167047 Tetrahydorquinoline derivatives and their use as fsh receptor modulators |
| 07/27/2006 | US20060167046 Histamine h3 receptor antagonists, preparation and therapeutic uses |
| 07/27/2006 | US20060166954 Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester |
| 07/27/2006 | US20060166866 Cell adhesion inhibitors |
| 07/26/2006 | EP1683785A1 Urea derivative and process for producing the same |
| 07/26/2006 | EP1682511A2 Methods and compositions for selectin inhibition |
| 07/26/2006 | EP1682510A2 Methods and compositions for selectin inhibition |
| 07/26/2006 | EP1682491A1 Non-symmetrical gelling agent |
| 07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/26/2006 | CN1809556A Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 07/26/2006 | CN1809537A Method of producing ethyl (3r, 5s, 6e)-7-[2 cyclopropyl-4-(fluorophenyl) quinoline-3-yl]-3, 5-dihydroxy-6-heptenoate |
| 07/26/2006 | CN1807416A Ethoxy chinoline production method |
| 07/26/2006 | CN1266133C Process for preparing acetyl substituted nitrogen-containing heterocyclic compound |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2006 | US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone |
| 07/25/2006 | CA2395869C 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 07/25/2006 | CA2159603C Quinolines as type iv phosphodiesterase inhibitors |
| 07/25/2006 | CA2072785C Pharmacologically active hydrazine derivatives and processes for the preparation thereof |
| 07/20/2006 | WO2006075159A1 Anti-bacterial compounds |
| 07/20/2006 | WO2006074897A1 Cinnamate salts of a beta-2 adrenergic agonist |
| 07/20/2006 | WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 07/20/2006 | US20060160894 Benzamides as ppar modulators |
| 07/20/2006 | US20060160850 antagonists; regulation of appetite; obesity; smoking cessationp; [1-Benzyl-6-(2-methyl-2H-tetrazol-5-yl)-1,2,3,4-tetrahydroquinolin-3-yl]-carbamic acid cyclohexyl ester |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | CA2594484A1 Cinnamate salts of a beta-2 adrenergic agonist |
| 07/20/2006 | CA2593482A1 Heteroaryl substituted quinolin-4-ylamine analogues |
| 07/19/2006 | EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/19/2006 | EP1680397A2 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/19/2006 | EP1680119A1 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) |
| 07/19/2006 | EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/19/2006 | CN1805923A Benzamide derivative or salt thereof |
| 07/19/2006 | CN1803784A 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 07/19/2006 | CN1803774A Dichloro quinolinic acid, its preparation method and solid preparation thereof |
| 07/19/2006 | CN1264837C Antimicrobial quinolones, their compositions and uses |
| 07/19/2006 | CN1264514C Pediatric formulation of gatifloxacin |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078725 bis[2-(p-fluorophenyl)-5-trifluoromethylpyridine] complex of iridium(III) chloride carbonyl used to form the active layer in electronic devices |
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/13/2006 | WO2006074025A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 07/13/2006 | WO2006073973A2 Novel benzylamine derivatives as cetp inhibitors |
| 07/13/2006 | WO2006072362A1 (5s) -3-[(s)-fluoro (4-trifluoromethylphenyl) methyl]-5,6,7,8-tetrahydroquinoline-5-ol derivatives and use thereof as cetp inhibitors |
| 07/13/2006 | WO2006039718A3 Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors |
| 07/13/2006 | US20060155121 Substituted aniline derivatives |
| 07/13/2006 | US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria, |
| 07/13/2006 | CA2605214A1 Benzylamine derivatives as cetp inhibitors |
| 07/13/2006 | CA2596393A1 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions |
| 07/13/2006 | CA2591486A1 (5s) -3-[(s)-fluoro (4-trifluoromethylphenyl) methyl]-5,6,7,8-tetrahydroquinoline-5-ol derivatives and use thereof as cetp inhibitors |
| 07/12/2006 | EP1679303A1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative |
| 07/12/2006 | EP1679296A1 Ether derivative |
| 07/12/2006 | EP1678157A2 Heterocyclic compounds and methods of making and using thereof |
| 07/12/2006 | EP1678154A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 07/12/2006 | EP1678149A2 4-amino(aza)quinoline derivatives as capsaicin receptor agonists |
| 07/12/2006 | EP1678139A1 Solid-state montelukast |
| 07/12/2006 | EP1678121A2 Tao kinase modulators and methods of use |
| 07/12/2006 | EP1677797A2 Salts and polymorphs of a potent antidiabetic compound |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | EP1076648B1 Method for the catalytic production of substituted dipyridyl derivatives |
| 07/12/2006 | EP1025846B1 Aqueous liquid preparations |
| 07/12/2006 | CN1802156A Aminoquinoline compounds |
| 07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
| 07/12/2006 | CN1263743C Therapeutic morpholino-substituted compounds |
| 07/12/2006 | CN1263742C Process for preparing aripiprazole |
| 07/11/2006 | US7075102 cyclometalated complexes; organic light emitting devices |
| 07/11/2006 | US7074933 quinolin-2-ones and chromen-2-ones compounds that have been derivatized at the 6-position with a urea or thiourea derivative; used as androgen antagonists; kits |
| 07/11/2006 | US7074932 Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 07/11/2006 | US7074931 Reacting a 1,3-cyclohexanedione with a homo-chiral phenylethylamine, reacting assymmetric vinlogous amide with alpha-beta-unsaturated ketone in presence of a silicon compound to form asymmetric diketone, then dihydropyridine |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074836 Para-terphenyl compounds |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | US7074796 High affinity for D4 receptors; treatment of psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder. |
| 07/11/2006 | CA2168447C Compounds and methods for inhibition of hiv and related viruses |
| 07/11/2006 | CA2163244C Quinoline derivatives as leukotriene antagonists |
| 07/11/2006 | CA2123731C Process for the preparation of carboxamides of nitrogen-containing aromatic heterocyclic compounds and their use |
| 07/06/2006 | WO2006070394A1 Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors |
| 07/06/2006 | WO2006069656A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 07/06/2006 | WO2006043846B1 Salt of montelukast with tert.-butylamine |
| 07/06/2006 | WO2006017215A3 Histone deacetylase inhibitors |
| 07/06/2006 | US20060149043 novel complex comprising a substituted 2quinolinol and a lanthanide ion, more specifically, to a novel long-life luminescent complex comprising a substituted 2-quinolinol and a lanthanide ion, the luminescence intensity of which can be controlled using a photo-induced electron transfer (PET) |
| 07/06/2006 | US20060148849 Quinoline derivatives, process of synthesis and medicaments containing these derivatives |
| 07/06/2006 | US20060148815 4-Phenyl-1-piperazinyl, -piperidinyl and-tetrahydropyridyl derivatives |
| 07/06/2006 | US20060148806 Quinolone derivative or salt thereof |
| 07/06/2006 | US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity |
| 07/06/2006 | US20060148043 Novel optically active, heteroaromatic beta-hydroxy esters and processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters |
| 07/06/2006 | DE202005020551U1 7-(4-Brombutoxy)-3,4-dihydrocarbostyril 7- (4-bromobutoxy) -3,4-dihydrocarbostyril |
| 07/06/2006 | CA2592514A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 07/06/2006 | CA2592430A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 07/05/2006 | EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
| 07/05/2006 | EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |